Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,525-1,536 of 4,306
Drug study icon
Not recruitingISRCTN24109245

Vulnerability markers in the association between cannabis and schizophrenia

This study is testing a medication approach for people with Cannabis use and psychosis, Mental and Behavioural Disorders, or Mental and behavioural disorders due to use of cannabinoids. Participants receive a study treatment and complete follow-up visits and assessments.

In Australia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
Australia
Sponsor
University of Wollongong (Australia)
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2021-002572-39

Effects of add-on Celecoxib treatment in patients with schizophrenia spectrum disorders and inflammatory cytokine profile (TargetFlame)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Germany
Sponsor
Bezirkskliniken Schwaben
Condition
Schizophrenia
Drug study icon
CompletedNCT02507206

A D1 Agonist For Working Memory

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Antonia New
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01081418

Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Hamburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Condition
Schizophrenia
Other study type icon
CompletedNCT03068806

Brain Imaging, Attention, and Auditory Processing in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 75 Years
Countries
United States
Sponsor
San Francisco Veterans Affairs Medical Center
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01876056

Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Lahore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Pakistan
Sponsor
Pakistan Association of Cognitive Therapists
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT04105231

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

This summary needs review. Please check the official study record and contact the research team for details.

In Glostrup Municipality
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Denmark
Sponsor
Lone Baandrup
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01701609

Cognitive Remediation Therapy (CRT) in Adolescents With EOS

This summary needs review. Please check the official study record and contact the research team for details.

In Barcelona
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 12 Years to 18 Years
Countries
Spain
Sponsor
Hospital Clinic of Barcelona
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.